ArticleCancer chemotherapy and pharmacology2022

Efficacy and safety exposure-response analyses of entrectinib in patients with advanced or metastatic solid tumors.

Francois Mercier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.